D1SportsNetwork Launches TourneyManager to Simplify Event Management and Eliminate Traditional Fees Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1; in all five…
Fivetran Named Databricks Data Ingestion Partner of the Year
Extensive Slate of New Product Enhancements Unveiled OAKLAND, Calif.–(BUSINESS WIRE)–Fivetran, the global leader in modern…
TripStack and Navitaire Announce Strategic Partnership to Bring Virtual Interline Technology to Airlines
TORONTO & MINNEAPOLIS–(BUSINESS WIRE)–#virtualinterline–TripStack and Navitaire announced today that the companies have entered into a…
KBRA Europe Releases Research – Battery Storage Funding Critical to Europe’s Energy Transition
DUBLIN–(BUSINESS WIRE)–#KBRA–KBRA Europe (KBRA) releases a report on current funding methods for battery storage in…
Academic, Industry Leaders Form OpenFold AI Research Consortium to Develop Open Source Software Tools To Understand Biological Systems and Discover New Medicines
Founders of the non-profit consortium also announce release of its first AI model to predict protein…
Genius Sports Partners With Clue to Launch the Most Advanced Integrity Intelligence System in Sport
Genius Sports’ is the integrity partner to over 150 leagues and federations around the world,…
Vortex 6 Launches V6 ProFusion Transforming the Way Organizations Track Employee IT Certifications to Build a Live Skills Taxonomy
ProFusion provides vital business intelligence to impact everything from strategy to L&D investment, through a…
Totalmobile Launches Field Service Intelligence Solution Allowing Customers to Review Operational Performance as Services Take Place
Insight from Totalmobile provides users with access to real time operational data and predictive intelligence…
Ransomware volume already doubled 2021 total by end of Q1 2022 says WatchGuard Threat Lab Report
New research shows Log4Shell detections tripled, PowerShell scripts heavily influenced a surge in endpoint attacks,…
Crossword Cybersecurity Plc announces new Supply Chain Cyber practice in response to increasing threat of supply chain cyber attacks
New integrated practice addresses 4x forecast growth in supply chain cyber attacks 28 June 2022…
FullCircl Partners with Codat to create a frictionless and personalised experience for financial service providers onboarding and serving SME customers
London, 28th June 2022: FullCircl, the Customer Lifecycle Intelligence (CLI) platform that helps B2B companies…
Iskratel unlocks next-generation broadband technologies for Telekom Slovenije
The universal Iskratel Lumia C16 delivers much needed versatility and flexibility for urban and rural…
Blancco achieves goal of becoming carbon neutral
Global leader in data sanitization affirms commitment to sustainability by achieving carbon neutrality in line…
Mainz Biomed Enrolls First Patient in ColoFuture Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert
Multi-center clinical trial impacting ColoAlert’s profile for FDA submission On track to report results by…
MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis
GHENT, Belgium, June 28, 2022 (GLOBE NEWSWIRE) — MRM Health, a clinical-stage biopharmaceutical company developing…
6,214 Orion Corporation A shares converted into B shares
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE…
Bavarian Nordic Announces Grant of PRIME Eligibility from the European Medicines Agency for its RSV Vaccine Candidate for the Prevention of Respiratory Syncytial Virus in Older Adults
COPENHAGEN, Denmark, June 28, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the…
Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD
Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD Paris,…
Press Release: Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease
Nexviadyme®(avalglucosidase alfa) approved by European Commission as a potential new standard of care for the…
Basilea announces positive results of phase 3 ERADICATE study with ceftobiprole in Staphylococcus aureus bacteremia (SAB)
Ceftobiprole met primary and secondary efficacy endpoints Basilea plans to submit a New Drug Application…